Leaflet SERMION 30mg film-coated tablets

Product code:
W65107002
Quantity:
30
Indicated for:
cognitive disorders; cerebral circulatory disorders
Route of administration:
oral
Substance:
nicergoline (alkaloid derivative)
ATC
C04AE02 — Cardiovascular system | Peripheral vasodilators | Peripheral vasodilators | Ergot alkaloids
Nicergoline is a medication used to improve cerebral circulation and treat age-related cognitive and vascular disorders, such as vascular dementia, ischemic strokes, or chronic cerebral circulatory insufficiency. It is derived from ergot and has vasodilatory effects, enhancing blood flow to the brain.

Nicergoline works by increasing oxygen and glucose utilization by brain cells, reducing platelet aggregation, and improving cerebral metabolism. It is commonly used for symptoms such as dizziness, memory problems, confusion, headaches, or difficulty concentrating.

Side effects may include nausea, dizziness, low blood pressure (hypotension), insomnia, or allergic reactions. It is important to take the medication as prescribed by a doctor, and patients should be monitored to avoid complications.
SERMION 30mg film-coated tablets PFIZER, nicergoline

General data about SERMION 30mg

Substance:
nicergoline
Date of latest medicines list:
01-06-2026
Product code:
W65107002
Concentration:
30mg
Pharmaceutical form:
film-coated tablets
Quantity:
30
Product type:
Original
Prescription status:
P-6L — Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.

Marketing authorisation

Manufacturer:
PFIZER ITALIA S.R.L. - ITALIA
Holder:
PFIZER EUROPE MA EEIG - BELGIA
Number:
11445/2019/02
Shelf life:
3 years

Concentrations available for nicergoline

  • 10mg
  • 15mg
  • 30mg
  • 4mg
  • 5mg